70
Participants
Start Date
June 26, 2020
Primary Completion Date
February 28, 2021
Study Completion Date
February 28, 2021
Continuous vital signs and glucose monitoring
"The patients will have the following parameters and vital signs continuously monitored using wireless equipment:~* Glucose measurements (quasi-continuous, every 5 minutes)~* Heart rate~* Heart rhythm (single-lead ECG; quasi-continuous, 10 seconds every minute)~* Signs of cardiac ischemia (single-lead ECG; quasi-continuous, 10 seconds every minute)~* Respiration rate~* Oxygen saturation of arterial hemoglobin (%SpO2)~* Perfusion index (ratio of the pulsatile blood flow to the non-pulsatile or static blood in peripheral tissue)~* Blood pressure (quasi-continuous; every 30-60 minutes)~* Skin temperature~* Electrodermal activity~* Ambulatory activity (accelerometry)"
Rigshospitalet, Copenhagen
Bispebjerg Hospital, Copenhagen
Rigshospitalet, Denmark
OTHER
University Hospital Bispebjerg and Frederiksberg
OTHER